Callisto DataHub

The central hub to buy medical images and clinical data

Callisto provides high-quality, annotated radiological/pathological scans and clinical/molecular diagnostic data collected from Japanese hospitals/clinics

1. Higher AI performance

We offer millions of high-quality, (annotated) scans—both radiological and pathological—along with clinical and molecular diagnostic data to boost your AI model’s accuracy, reliability, and functionality. Our datasets, collected from Japanese hospitals/clinics, are particularly ideal for R&D targeting Japan or Asian demographics. Longitudinal data for pharma and life science are also available.

Radiological and pathological scans

Radiological scans (X-ray, CT, MRI, mammography, PET, etc.), ultrasound scans, and pathology scans (WSI).

Annotations

Disease segmentations and radiology/pathology reports, annotated and verified by expert radiologists/pathologists. Lung field segmentations are also available. Note: Annotations are generally available only for major diseases.

Clinical information

Age, sex, height, weight, medical history/family history, surgical history, main complaint, major symptoms/progress, nursing observation record, referring department, diagnosis, etc. Molecular diagnostic results may be available, such as ER, PgR, HER2 positive/negative in the case of breast cancer.

2. Shorter R&D cycle

Our datasets, ethically-reviewed, de-identified, and meticulously curated, are ready-to-use for your R&D in medical AI, drug discovery AI, and clinical trials. We can provide dataset samples, dataset customization, and data-related consulting services, including medical feedback, customized AI development, and regulatory support for entering the Japanese medical device market.

No ethical review required

Passed ethical reviews for secondary use, eliminating the need for further ethical reviews.

Anonymized

Rigorously de-identified to ensure legal compliance, safeguarding you from compliance risk.

Carefully-curated

Data unsuitable for medical AI, such as cases with complications or excessive noise, are excluded. Our comprehensive standardization of images, clinical data, molecular diagnostic data, and annotations minimizes additional pre-processing and verification.

3. Lower R&D cost

You do not need to heavily invest in collecting, selecting, annotating, and pre-processing various medical data by yourself. Our datasets are versatile and ready for use across a wide range of R&D applications, such as medical AI, drug discovery AI, and clinical trials.

Medical AI

Examples: Image diagnosis, automatic contour extraction, and dose distribution creation.

Drug discovery AI

Examples: Drug screening, biomarker discovery, and therapeutic target identification.

Clinical trials

Examples: Clinical trial design, drug toxicity/effectiveness evaluation, and histopathological assessment.

Get started now

Looking for de-identified datasets from Japan?

Looking for high-quality annotated medical image datasets?

Looking for radiological/pathological scans and clinical/molecular diagnostic data, with specific diseases?

To celebrate the launch of DataHub, we are offering a free dataset featuring 152 lung cancer CT cases with detailed annotations of lung cancer and lung field segmentations.

FAQ

Company

Name

Callisto Inc.

Business

①Operating a medical image data platform for medical AI/drug discovery AI R&D

②Providing development and consulting services for custom drug discovery AI/medical AI solutions

Executives

CEO: Changhee Han (Kallis)

External Director: Yumi Kato

Location

18F Shinjuku Sumitomo Building, 2-6-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo 160-0023, Japan

TEL

(+81) 3-6887-1384

Established

June 27, 2022

Employee Count

23 (including executives, interns, and subcontractors, as of October 2024)

Investors

Itochu Technology Ventures

NOW

Funds Raised

200 million yen

QHow is the pricing for datasets determined?

QWhat payment methods do you accept?

QCan datasets be customized to use only certain parts?

QDo you offer sample data?

QDo you provide consulting services related to data?